MRÁZ, Marek, Václav ŠEDA and Laura ONDRIŠOVÁ. Inhibitors for treatment of hematological malignancies. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Inhibitors for treatment of hematological malignancies
Authors MRÁZ, Marek (203 Czech Republic, guarantor, belonging to the institution), Václav ŠEDA (203 Czech Republic, belonging to the institution) and Laura ONDRIŠOVÁ (703 Slovakia, belonging to the institution).
Edition Number: US11648255B2, Publisher: United States Patent and Trademark Office, Place of publication: Alexandria, Virginia, USA, Owner's name: Masarykova univerzita; Fakultní nemocnice Brno; 2023.
Other information
Original language English
Type of outcome Patent
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW Link na PDF dokument na stránkách Google Patents
RIV identification code RIV/00216224:14740/23:00132965
Organization unit Central European Institute of Technology
Keywords in English treatment of hematological malignancies;GAB1 inhibitor;BTK inhibitor; haematology;
Tags rivok
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 2/4/2024 09:46.
Abstract
A new approach to treatment of hematological malignancies. A GAB1 inhibitor for use in a method of treatment of a hematological malignancy is disclosed. The GAB1 inhibitor may be administered alone, or simultaneously or sequen-tially with a BTK inhibitor to achieve a synergistic effect.
PrintDisplayed: 25/8/2024 16:19